[HTML][HTML] LncRNAs in ovarian cancer progression, metastasis, and main pathways: ceRNA and alternative mechanisms

EA Braga, MV Fridman, AA Moscovtsev… - International journal of …, 2020 - mdpi.com
Ovarian cancer (OvCa) develops asymptomatically until it reaches the advanced stages with
metastasis, chemoresistance, and poor prognosis. Our review focuses on the analysis of …

The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance–a focus on signaling pathways interplay

A Ismail, AI Abulsoud, D Fathi, A Elshafei… - … -Research and Practice, 2022 - Elsevier
One of the most prevalent and lethal forms of gynecological cancer is ovarian cancer (OC),
which is often diagnosed in its latter, deadly stages. The OC's high mortality and …

[HTML][HTML] Mechanisms of ovarian aging in women: a review

X Wang, L Wang, W Xiang - Journal of Ovarian Research, 2023 - Springer
Ovarian aging is a natural and physiological aging process characterized by loss of quantity
and quality of oocyte or follicular pool. As it is generally accepted that women are born with a …

[HTML][HTML] Effect of endothelial progenitor cell-derived extracellular vesicles on endothelial cell ferroptosis and atherosclerotic vascular endothelial injury

L Li, H Wang, J Zhang, X Chen, Z Zhang, Q Li - Cell death discovery, 2021 - nature.com
Atherosclerosis (AS) is a chronic inflammatory disorder characterized by endothelial
dysfunction. Endothelial progenitor cells (EPCs) can overcome endothelial dysfunction and …

[HTML][HTML] Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis

S Sun, H Fang - Journal of Ovarian Research, 2021 - Springer
Background Curcumin has a potential therapeutic role in ovarian cancer. However, whether
curcumin plays anti-cancer role in ovarian cancer by mediating the circular RNA …

[HTML][HTML] Ovarian Cancer—Insights into Platinum Resistance and Overcoming It

A Havasi, SS Cainap, AT Havasi, C Cainap - Medicina, 2023 - mdpi.com
Ovarian cancer is the most lethal gynecologic malignancy. Platinum-based chemotherapy is
the backbone of treatment for ovarian cancer, and although the majority of patients initially …

Unlocking exosome-based theragnostic signatures: deciphering secrets of ovarian cancer metastasis

S Mukherjee, S Nag, N Mukerjee, S Maitra… - ACS …, 2023 - ACS Publications
Ovarian cancer (OC) is a common gynecological cancer worldwide. Unfortunately, the lack
of early detection methods translates into a substantial cohort of women grappling with the …

[HTML][HTML] Mesothelial-to-mesenchymal transition and exosomes in peritoneal metastasis of ovarian cancer

L Pascual-Antón, B Cardeñes… - International journal of …, 2021 - mdpi.com
Most patients with ovarian cancer (OvCA) present peritoneal disseminated disease at the
time of diagnosis. During peritoneal metastasis, cancer cells detach from the primary tumor …

[HTML][HTML] YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells

J Li, L Wu, M Pei, Y Zhang - Journal of ovarian research, 2020 - Springer
RNA methylation can reverse the methylation modification at the RNA level, which is an
extremely important epigenetic modification. The function and mechanism of YTHDF2, as a …

[HTML][HTML] Tumor-derived extracellular vesicles promote activation of carcinoma-associated fibroblasts and facilitate invasion and metastasis of ovarian cancer by …

Y Cui, D Wang, M Xie - Frontiers in cell and developmental biology, 2021 - ncbi.nlm.nih.gov
Ovarian cancer (OC) is a lethal gynecological malignancy. Extracellular vesicles (EVs) are
crucial media in cell-to-cell communication by carrying microRNAs (miRs). The current study …